Aperture Investors, LLC Astrazeneca PLC Transaction History
Aperture Investors, LLC
- $698 Million
- Q1 2024
A detailed history of Aperture Investors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Aperture Investors, LLC holds 33,732 shares of AZN stock, worth $2.63 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
33,732
Previous 4,340
677.24%
Holding current value
$2.63 Million
Previous $292,000
682.53%
% of portfolio
0.33%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,246Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...